Instem is proud to be attending BioAsia 2026, one of the world’s leading life sciences and biotechnology events, bringing together innovators from across pharma, biotech, CROs, academia and regulatory bodies.
At BioAsia 2026, our team will be showcasing how Instem’s regulatory-driven software and scientific solutions help organisations accelerate discovery, improve data integrity, and confidently navigate global regulatory requirements, all in support of safer, more effective therapies reaching patients faster.
Visit us at Booth 64 to learn more about our leading software & services, including:
Provantis®
Streamlines end-to-end workflows for preclinical study management. Ask about our new Non-GLP Pathology module!
An electronic laboratory notebook (ELN) that simplifies and streamlines the digitization and documentation of lab processes.
SEND Advantage™ Outsourced Services and Consulting
A suite of services that ensure your nonclinical data meets the Standard for Exchange of Nonclinical Data (SEND) submission requirements.
Submit™ Seamless Electronic SEND Submissions
Improves the speed and quality of new pharmaceutical developments by enabling the efficient exchange of critical study data between sponsors, CROs, and regulators.
BioRails®
A comprehensive suite of advanced modules designed to streamline workflows, schedules, and data management across experimental pipelines in drug discovery.
Cyto Study Manager™
Enables improved management of genotoxicity studies, delivering enhanced accuracy, documentation, and compliance.
Leadscope Model Applier™
An advanced In Silico toxicology tool that helps scientists predict toxicity endpoints, review results with confidence, and generate regulatory-compliant reports.
KnowledgeScan™
Technology-enabled Target Safety Assessment service, enabling researchers to make smarter, faster, and data-driven decisions.
Centrus®
This powerful tool consolidates and structures data from various sources into a unified, accessible platform, enabling high-quality data management and seamless data sharing for early-stage research.
Advance™
A comprehensive solution supporting the ICH S1B Weight of Evidence Addendum for assessing carcinogenicity risk. Advance streamlines early-stage safety evaluations, reducing costs, saving valuable time, and minimizing the need for animal testing.
Predict™
Our Predict service uses advanced QSAR techniques to streamline early-stage safety assessments through predictive modeling. Enables researchers to evaluate potential toxicity risks quickly, supporting data-driven decision-making and reducing the need for subject testing.
Want to talk in more detail? Contact us to schedule a 1:1 meeting. We look forward to seeing you there!
For more information, visit the Event Website
